Follow us on Twitter
twitter icon@FreshPatents


Inhaler patents

      

This page is updated frequently with new Inhaler-related patent applications.




 Powder inhaler and powder inhalation set patent thumbnailnew patent Powder inhaler and powder inhalation set
The invention relates to a powder inhaler and to a powder inhaler set that contains the powder inhaler. The powder inhaler comprises two half-shells (3, 4), which are connected to each other by means of at least one film hinge and are formed as a single piece.

 Powder inhaler and powder inhalation set patent thumbnailnew patent Powder inhaler and powder inhalation set
The invention relates to a powder inhaler and to a powder inhaler set that contains the powder inhaler. The powder inhaler comprises two half-shells (3, 4), which can be or are articulated to each other and which enclose an air inlet region, a powder deposition region and powder release region, and an outlet region in a joined arrangement, through which regions a fluid path extends.

 Compliance monitoring module for a breath-actuated inhaler patent thumbnailCompliance monitoring module for a breath-actuated inhaler
A compliance monitoring module for a breath-actuated inhaler comprising: a miniature pressure sensor, a sensor port of said sensor being pneumatically coupled to a flow channel through which a user can inhale; a processor configured to: receive a signal originating from a dosing mechanism of the inhaler indicating that medication has been released; receive data from a sensing element of the sensor; and based on said signal from said dosing mechanism and said data from said sensing element, make a determination that inhalation of a breath containing medication through said flow channel complies with one or more predetermined requirements for successful dosing; and a transmitter configured to, responsive to said determination, issue a dosing report. .
Norton (waterford) Limited


 Powder inhaler devices patent thumbnailPowder inhaler devices
An improved inhalation device is provided for facilitating inhalation by a patient of powder medicaments contained in a receptacle. The inhalation device includes a staple assembly comprising a plunger and staple that are securely and robustly coupled to one another.
Civitas Therapeutics, Inc.


 Non-combustion-type flavor inhaler patent thumbnailNon-combustion-type flavor inhaler
A non-combustion-type flavor inhaler includes a shape extending from a non-mouthpiece end to a mouthpiece end in a predetermined direction. The non-combustion-type flavor inhaler includes: an aerosol source generating aerosol; an atomizer atomizing the aerosol source without combustion; a power source supplying electric power to the atomizer; and a controller controlling an electric energy supplied from the power source to the atomizer.
Japan Tobacco Inc.


 Heating system and  heating for an inhaler device patent thumbnailHeating system and heating for an inhaler device
A heating system (3) for an inhaler device (1), such as an e-cigarette or a personal vaporizer, for generating an aerosol and/or a vapor (v) from a substance to be heated, especially a liquid or gel, the heating system (3) including: a first heating zone (5) configured to receive the substance to be heated from a supply reservoir (4), wherein at least one first heating element (14) is provided to pre-heat the substance in the first heating zone (5); and a second heating zone (16) configured to receive the preheated substance from the first heating zone (5), wherein at least one second heating element (19) is provided to heat the substance in the second heating zone (16).. .
Jt International S.a.


 Compliance monitoring module for a breath-actuated inhaler patent thumbnailCompliance monitoring module for a breath-actuated inhaler
A compliance monitoring module for a breath-actuated inhaler comprising: a miniature pressure sensor, a sensor port of said sensor being pneumatically coupled to a flow channel through which a user can inhale; a processor configured to: receive a signal originating from a dosing mechanism of the inhaler indicating that medication has been released; receive data from a sensing element of the sensor; and based on said signal from said dosing mechanism and said data from said sensing element, make a determination that inhalation of a breath containing medication through said flow channel complies with one or more predetermined requirements for successful dosing; and a transmitter configured to, responsive to said determination, issue a dosing report.. .
Norton (waterford) Limited


 Particulate materials patent thumbnailParticulate materials
The present invention relates to active substances in particulate form, to methods for preparing them and to their uses. The present invention provides particulate powders, such as might be of use for delivery using a dry powder inhaler (dpi) or similar delivery device, having properties which may be beneficial to the dpi delivery process..
Nektar Therapeutics


 Aerosol formulations comprising formoterol fumarate dihydrate patent thumbnailAerosol formulations comprising formoterol fumarate dihydrate
The invention provides a method of producing a highly stable pharmaceutical aerosol suspension formulation suitable for use in a metered dose inhaler, the formulation comprising formoterol fumarate di-hydrate in suspension, a steroid in suspension, a propellant and ethanol, the method comprising the steps of drying the formoterol fumarate di-hydrate to a water content of 4.8 to 4.28%.. .
Jagotec Ag


 Heating system and  heating for an inhaler device patent thumbnailHeating system and heating for an inhaler device
A heating system for an inhaler device, such as an e-cigarette or a personal vaporizer, for generating an aerosol and/or a vapor from a substance to be heated includes at least one supply channel for conveying a substance to be heated, especially a liquid solution or a gel, from a supply reservoir by or under capillary action or surface tension forces, and a heater configured to heat the substance as it is conveyed through the at least one channel.. .
Jt International S.a.


Inhalable medicaments

The present invention provides a dry powder inhaler comprising: a reservoir containing a dry powder formulation and an arrangement for delivering a metered dose of the medicament from the reservoir; a cyclone deagglomerator for breaking up agglomerates of the dry powder medicament; and a delivery passageway for directing an inhalation-induced air flow through a mouthpiece, the delivery passageway extending to the metered dose of medicament, wherein the formulation comprises an inhalable β2-agonist having a particle size distribution of d10<1 μm, d50=1-3 μm, d90=3.5-6 μm and nlt 99% 10 μm and a lactose carrier.. .
Pharmachemie B.v.

Dry powder inhaler

This invention provides a budesonide/formoterol dry powder inhaler (10) comprising: •a reservoir (14) containing a dry powder medicament and an arrangement for delivering a metered dose of the medicament from the reservoir; •a cyclone deagglomerator (10′) for breaking up agglomerates of the dry powder medicament; •a delivery passageway/34) for directing an inhalation-induced air flow through a mouthpiece (24), the delivery passageway extending to the metered dose of medicament, •wherein the medicament comprises micronised formoterol fumarate, micronised budesonide and a lactose carrier, the lactose carrier having a particle size distribution of d10=20-65 μm, d50=80-120 μm, d90=130-180 μm and <10 um=<10%.. .
Pharmachemie B.v.

Novel dosage form and formulation of abediterol

The present invention provides a pharmaceutical composition in the form of a dry powder for inhalation comprising abediterol or a pharmaceutically acceptable salt in admixture with a pharmaceutically acceptable carrier, providing upon inhalation a dose equivalent to a metered nominal dose of about 1.25 or about 2.5 micrograms of free base abediterol administered with the genuair® inhaler. The present invention also provides said pharmaceutical composition for use in the treatment of respiratory disease such as asthma and chronic obstructive pulmonary disease copd..
Almirall, S.a.

Stable pressurized aerosol solution composition of glycopyrronium bromide and formoterol combination

Aerosol solution compositions intended for use with a pressurized metered dose inhaler, comprising glycopyrronium bromide and formoterol, or a salt thereof or a solvate of said salt, optionally in combination with one or more additional active ingredients, and stabilized by a selected amount of a mineral acid, exhibit improved stability when contained in a can internally coated by a resin comprising a fluorinated ethylene propylene (fep) polymer.. .
Chiesi Farmaceutici S.p.a

Stable pressurized aerosol solution composition of glycopyrronium bromide and formoterol combination

Aerosol solution compositions intended for use with a pressurized metered dose inhaler, comprising glycopyrronium bromide and formoterol, or a salt thereof, optionally in combination with one or more additional active ingredients, and stabilized by a selected amount of a mineral acid, exhibit improved stability when contained in an aerosol can provided with a metering valve having at least a butyl rubber gasket.. .
Chiesi Farmaceutici S.p.a.

Garment for concealing a hands-free oral delivery device

The invention disclosed herein provides a garment capable of providing a user with improved convenience and privacy. The invention includes a garment for concealing a hands-free oral delivery device with a fluid container and a pocket configured to hold the fluid container.

Airflow testing an inhaler

Testing apparatus comprising an air pump downstream of measuring equipment which measures the characteristics of an inhaler is provided. An induction port upstream of the measuring equipment has an adaptor connected at a first end.
Kind Consumer Limited

Blister strip advance mechanism

A blister strip advance mechanism includes: an indexing gear train; drive mechanism configured to drive the indexing gear train; and a hub including a recess shaped to engage a first blister of a blister strip, the hub being rotatable by the indexing gear train to engage the first blister in the recess and move the engaged blister strip such that a second blister is moved to a dosing position at which the second blister can be emptied; wherein the indexing gear train is configured to temporarily disengage the drive mechanism from the hub when the second blister is in the dosing position. Also disclosed is a dosing mechanism including the blister strip advance mechanism; an inhaler including the dosing mechanism; a method for advancing a blister strip; and a method for dosing a medicament including the method for advancing a blister strip..
Microdose Therapeutx, Inc.

Dry powder drug delivery system

A pulmonary drug delivery system is disclosed, including a breath-powered, dry powder inhaler, and a cartridge for delivering a dry powder formulation. The inhaler and cartridge can be provided with a drug delivery formulation comprising, for example, a diketopiperazine and an active ingredient, including, peptides and proteins such as insulin and glucagon-like peptide 1 for the treatment of endocrine disease, for example, diabetes and/or obesity..
Mannkind Corporation

Improved vaporization and disage control for electronic vaporization

The present invention provides an electronic vaporizing inhaler with an electrical storage device; a liquid reservoir for vaping liquid; a vaporizer with a substrate defined by a plurality of capillary apertures that provide fluid communication between the vaporizer and the liquid reservoir; a sponge; a wick; and a heating element; a microprocessor in electrical communication with the electrical storage device that directs current from the electrical storage device to the heating element in the vaporizer; a sensor configured to detect when a user draws on the electronic cigarette that activates the microprocessor when it detects that a user has drawn on the electronic cigarette; a housing having designed to contain the electrical storage device, vaporizer, microprocessor, sensor, and liquid reservoir and having a mouthpiece from which a user can inhale vapor from the vaporizer. The invention also provides a dosage control embodiment using a heat or diaphragm pump..
Ctc Technologies, Llc

Inhaler for the administration of an anticholinergic

An inhaler for administration of powdered preparations containing tiotropium, wherein the inhaler displays a flow resistance of 0.01-0.1 √{square root over (kpa)} min/l and comprises a housing, a deck with air inlet ports and a screen secured by a screen housing, an inhalation chamber connected to the deck on which there is a push button provided with two sharpened pins and movable counter to a spring, a mouthpiece which is connected to the housing, the deck and a cover via a spindle to enable the cover to be flipped open or shut, and three holes with diameters below 1 mm in a central region of the deck around a capsule chamber and underneath the screen housing and screen.. .
Boehringer Ingelheim Pharma Gmbh & Co. Kg

Inhaler device

An inhaler device for facilitating the inhalation of a medicament from a pierceable medicament capsule, the inhaler device including a body having a chamber for receiving a pierceable medicament capsule, piercing means for piercing a medicament capsule received in the chamber, an actuating member moveable relative to the body, and a plurality of cam members and a cam track. One movement of the actuating member relative to the body causes one of the cam members to move along the cam track in abutment therewith, the piercing means thereby being pressed from a retracted position to an extended position and another movement of the actuating member relative to the body causes the other one of the cam members to move along the cam track in abutment therewith so that the piercing means is pressed from an extended position towards a retracted position..
Cipla Limited

Mouthpiece and inhaler

A mouthpiece for a handheld inhaler is disclosed. A housing of the mouthpiece includes an inlet, an outlet opening, and a channel extending through the housing connecting the inlet and the outlet opening for directing an aerosol from the inlet to the outlet opening.
Carebay Europe Ltd

Inhaler and atomizing assembly thereof

An inhaler and an atomizing assembly thereof are provided. The liquid reservoir is sealed before use, such that the liquid stored in the liquid reservoir will not be volatile, thus prolonging the life use of the inhaler.
Shenzhen Smoore Technology Limited

Preservative-free single dose inhaler systems

An aerosolization system includes a container that is configured to deliver a unit dosage of a liquid when squeezed a single time. The system also includes an aerosolizer that is constructed of a housing defining a mouthpiece, and an aerosol generator disposed in the housing.
Dance Biopharm Inc.

Medicament inhaler

The invention provides a dry powder inhaler comprising a mouthpiece for patient inhalation, a cover movable about a hinge to open and close the mouthpiece, a delivery passageway for directing an inhalation induced air flow through the mouthpiece, a channel extending from the delivery passageway, a reservoir for containing medicament, the reservoir having a dispensing port connected to the channel, a cup received in the channel and movable between the dispensing port and the delivery passageway, wherein the cup comprises a cup cam follower, a cup spring biasing the cup towards the delivery passageway, a yoke movable between at least a first position and a second position and including a yoke cam, whereby closing the cover moves the yoke between the first position and the second position such that the yoke cam engages the cup cam follower and urges the cup against the cup spring to the dispensing port, and wherein the yoke cam, the cup cam follower, or both, is lubricated.. .
Norton (waterford) Limited

Delivery system for metered dose inhalers

A device for delivering medications with hydroflouroalkane propellant driven metered-dose inhalers (mdis). The device includes a collapsible bag to which is attached a bidirectional mouthpiece and an adaptor that receives the mdi.

Usage monitoring attachment for medicament dispenser

Systems and methods are described for monitoring usage of a medicament dispenser—particularly an inhaled medicament dispenser. While operating in a low-power mode, a first sensor is monitored for a signal indicative of handling of the medicament dispenser by a user.
Reciprocal Labs Corporation (d/b/a Propeller Health)

Dosage inhaler

A dosage inhaler includes an active liquid container, which contains a liquid having an active ingredient dissolved therein, and an atomizer by which the liquid is transformed into an aerosol and can be introduced into an aerosol dome, in which there is a baffle plate and to which an inlet tube and an outlet tube are attached, and an electronic control. The atomizer can be intermittently operated by a user and the user command readout is visible to the user.
United Therapeutics Corporation

Dry powder drug delivery system and methods

A pulmonary drug delivery system is disclosed, including a breath-powered, dry powder inhaler, and a cartridge for delivering a dry powder formulation. The inhaler and cartridge can be provided with a drug delivery formulation comprising, for example, a diketopiperazine and an active ingredient, including, small organic molecules, peptides and proteins, including, insulin and glucagon-like peptide 1 for the treatment of disease and disorders, for example, endocrine disease such as diabetes and/or obesity..
Mannkind Corporation

Dry powder inhaler

This invention provides a dry powder inhaler comprising: a dry powder medicament comprising fluticasone propionate, salmeterol xinafoate and a lactose carrier; wherein, the delivered dose of salmeterol per actuation is less than 50 μg; and wherein the dose provides a baseline-adjusted fev1 in a patient of more than 150 ml within 30 minutes of receiving the dose. A method of treating a patient includes administering to a patient a dry powder medicament having fluticasone propionate, salmeterol xinafoate and a lactose carrier; wherein, the delivered dose of salmeterol per actuation is less than 50 μg; and wherein the dose provides a baseline-adjusted fev1 in a patient of more than 150 ml within 30 minutes of receiving the dose..
Teva Branded Pharmaceutical Products R&d, Inc.

Method of making particles for use in a pharmaceutical composition

The invention relates to a method for making composite active particles for use in a pharmaceutical composition for pulmonary administration, the method comprising a milling step in which particles of active material are milled in the presence of particles of an additive material which is suitable for the promotion of the dispersal of the composite active particles upon actuation of an inhaler. The invention also relates to compositions for inhalation prepared by the method..
Vectura Limited

Blister track inhaler device having a separate end path and methods of use thereof

Embodiments of an inhaler device include a housing, a withdrawing assembly disposed within the housing for facilitating withdrawal of medicament from a target blister of a blister strip, the withdrawing assembly including an opening element adapted for opening the target blister of the blister strip while the target blister is positioned in the withdrawing assembly, and a dispensing element adapted for directing the withdrawn medicament toward the exterior of the inhaler device. A blister track is disposed within the housing for guiding each blister of the blister strip to the withdrawing assembly in succession, an advancing mechanism for advancing the blister strip by a predetermined distance each time the advancing mechanism is engaged, and an engaging element for engaging the advancing mechanism to advance the blister strip.
Novartis Ag

System for nitric oxide inhalation

A system for inhalation, comprising gas supply apparatus configured to separately supply at least no, and a carrier gas mixture which contains o2; a mixer apparatus configured for receiving gases from the supply apparatus and mixing the no with the carrier gas mixture to provide a therapeutic mixture; an inhaler device configured for receiving the therapeutic mixture and releasing the therapeutic mixture in an enclosed space of the inhaler device; a chemical sensing assembly configured for providing data pertaining to a concentration of at least no2 in the inhaler device; and a controller configured for controlling flow of the therapeutic mixture responsively to the data.. .
Advanced Inhalation Therapies (ait) Ltd.

Dry powder inhaler and system for drug delivery

A breath-powered, dry powder inhaler, a cartridge, and a pulmonary drug delivery system are provided. The dry powder inhaler can be provided with or without a unit dose cartridge for using with the inhaler.
Mannkind Corporation

A compliance monitor for a medicament inhaler

This invention relates to a compliance monitor for monitoring patient usage of a medicament inhaler. The medicament inhaler includes a store of medicament, a first housing for housing the store of medicament, a medicament dispensing means for delivering a dose of medicament, a mouthpiece for directing the dose of medicament into the mouth of a user, and a removable and replaceable cap for the mouthpiece.
Adherium (nz) Limited

Inhalation device and method

The present disclosure provides a method and device for delivering a pharmaceutical to the airway of a human or animal patient. In one aspect, the device includes a dose drum formed into a cylinder and including a plurality of dose compartments for containing individual doses.
Microdose Therapeutx, Inc.

Respiratory system simulator

An apparatus that simulates a respiratory system for characterizing particle delivery within lungs by an inhaler within lungs is shown and described. The respiratory system simulator comprises a simulated oral cavity to receive an aerosol, a simulated oropharynx cavity, a simulated lung airway system and a breath simulator.
Innovosciences, Llc

Metered dose inhaler and methods thereof

A process and a metered dose inhaler, comprising: an air actuator comprising at least one inlet of liquefied gas (lg), at least one air outlet, at least one first lg-expanding volume and at least one second air-containing volume, the first and second volumes are effectively separated by means of a lg-blocking member; a container with an lg source; said container is in a fluid connection with said lg-expanding volume via the at least one lg inlet; the air actuator is facilitating a metered dose airflow by allowing the expansion of said lg in said at least one lg-expanding volume from its condensed liquid phase to its expanded gas phase. The expansion of said lg facilitates the compression of the air within said at least one air-containing volume, such that a metered dose lg-free air flow is inhalable via at least one air outlet..
Meway Pharma Ltd

Dry powder inhalers comprising a carrier other than lactose and a ternary component

This invention relates to novel pharmaceutical compositions for inhalation comprising separately, sequentially or together, drugs having amine in the form of a dry powder in admixture with a pharmaceutically acceptable carrier, other than lactose, and its use in the treatment of respiratory condition selected from asthma and chronic obstructive pulmonary disease (copd) and other obstructive airways diseases. More particulary, the invention relates to pharmaceutical composition for inhalation further comprising a ternary component.
Arven Ilac Sanayi Ve Ticaret Anonim Sirketi

Dry powder inhaler

This invention provides a dry powder inhaler comprising: a dry powder medicament comprising fluticasone propionate, salmeterol xinafoate and a lactose carrier; wherein, the delivered dose of fluticasone propionate per actuation is less than 100 μg; and wherein the dose provides a baseline-adjusted fev1 in a patient of more than 150 ml within 30 minutes of receiving the dose. A method of treating a patient includes administering to a patient a dry powder medicament having fluticasone propionate, salmeterol xinafoate and a lactose carrier; wherein, the delivered dose of fluticasone propionate per actuation is less than 100 μg; and wherein the dose provides a baseline-adjusted fev1 in a patient of more than 150 ml within 30 minutes of receiving the dose..
Teva Branded Pharmaceutical Products R&d, Inc.

Non-burning type flavor inhaler

A non-burning type flavor inhaler includes: an aerosol source that generates an aerosol; an atomizer that atomizes the aerosol source without burning; a power source that supplies power to the atomizer; and a control unit that controls a power amount supplied from the power source to the atomizer. The control unit increases the power amount supplied to the atomizer stepwise from a reference power amount along with an increase in the number of puff actions for inhaling the aerosol..
Japan Tobacco Inc.

Non-burning type flavor inhaler and capsule unit

A non-burning type flavor inhaler includes a main body unit having the non-inhalation end; and a capsule unit configured to be attachable/detachable to/from the main body unit. The main body unit includes an aerosol source, an atomizer, and a power source.
Japan Tobacco Inc.

Non-burning type flavor inhaler

A non-burning type flavor inhaler includes a control unit that controls power supplied from a power source to an atomizer. The control unit controls, in one puff action in a standard mode, controls the power source to supply standard power amount to the atomizer in a duration before a first duration elapses.
Japan Tobacco Inc.

Non-burning type flavor inhaler

A non-burning type flavor inhaler includes an aerosol source that generates an aerosol; an atomizer that atomizes the aerosol source without burning; a power source that supplies power to the atomizer; a light-emitting element; and a control unit that controls the light-emitting element. The control unit controls the light-emitting element in a first light-emitting mode in a puff state inhaling the aerosol, and controls the light-emitting element in a second light-emitting mode different from the first light-emitting mode in a non-puff state not inhaling the aerosol.
Japan Tobacco Inc.

Powder dispersion methods and devices

A dry powder inhaler includes a powder storage element configured to hold a powdered medicament and an inlet channel receives powdered medicament from the powder storage element that is entrained in an airflow. The inlet channel has a first diameter and defines an opening.
Respira Therapeutics, Inc.

Dry-powder inhaler and method

A dry-powder inhaler comprising a housing comprising at least one air inlet to a first air passage and a second air passage extending from the first air passage and terminating in a mouthpiece; the housing thereby providing a continuous air passage through the at least one air inlet, the first and second air passages, and the mouth piece; a rigid, fixed, powdered-medicament reservoir comprising a base, the reservoir being associated with the first air passage, and together with the first air passage forming a powder chamber; wherein air passing through the powder chamber travels substantially parallel to an upper surface of the reservoir and powdered-medicament positioned on the base in the reservoir, the upper surface of the reservoir having a surface area, and the reservoir having a volume.. .
3m Innovative Properties Company



Inhaler topics:
  • Metered Dose Inhaler
  • Centimeter
  • Aerosolization
  • Pressure Sensor
  • Prophylaxis
  • Respiratory
  • Carbon Dioxide
  • Data Logging
  • Levalbuterol
  • Feedback Control
  • Degrees Of Freedom


  • Follow us on Twitter
    twitter icon@FreshPatents

    ###

    This listing is a sample listing of patent applications related to Inhaler for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Inhaler with additional patents listed. Browse our RSS directory or Search for other possible listings.


    3.6128

    file didn't exist2298

    469974 - 0 - 52